Medicinal Chemistry

ISSN: 2161-0444

Open Access

Identification, isolation, and characterization of bioactive compounds from Hypoestes aristata(Acanthaceae)


Tshifhiwa Ramabulana

The aim of this study was to identify and isolate potential biologically active compounds from the stems of Hypoestes aristata (Vahl) Sol. ex Roem. & Schult (Acanthaceae) and test them for their biological activities. The identification and isolation of potential bioactive compounds was achieved through chromatographic techniques such as column chromatography, preparative thin layer chromatography (PTLC), preparative high pressure liquid chromatography (Prep-HPLC), liquid chromatography-solid phase extraction-mass spectrometry (LC-SPE-MS), and ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-qTOF-MS). The characterisation and structural elucidation of the isolated compounds was mainly facilitated by spectroscopic/spectrometric techniques including 1D NMR (1HNMR, 13C-NMR, dept-135) and 2D NMR (COSY, HSQC, HMBC, NOESY) and high-resolution mass spectrometry (HRMS). From the stems of Hypoestes arisata, ten compounds that belong to the class of lignans were isolated and characterised. Among these compounds, four known butyrolactone lignans hinokinin, savinin, and cubebins; three new butyrolactone lignans (7S,8S,7’S,8’R)-7’-acetoxy-7-hydroxyhinokinin, (7S,8S,7’S,8’R)-7- acetoxy-7’-hydroxyhinokinin, and (7S,8S,7’S,8’R)-7,7’-diacetoxyhinokinin; and three new butyrolactol lignans. (7R,8S,9R,7′R,8′R)-7,7′-diacetoxycubebin, 7,7’-diacetoxy-β-cubebin, and (7S,8R,9S,7’R,8’R)-7,7’-diacetoxycubebin) were isolated. The absolute configurations of novel compounds were determined from their electronic circular dichroism (ECD) spectra and by derivatisation into (S) and (R)-MTPA esters. The newly isolated compounds are novel compounds. To the best of our knowledge, this is the first research which has isolated these compounds and confirms their absolute configurations from H. aristata. The compounds were screened for inhibition of a HIV-1 protease enzyme, hinokinin, (7S,8S,7’S,8’R)-7’-acetoxy-7-hydroxyhinokinin, (7S,8S,7’S,8’R)-7,7’- diacetoxyhinokinin, and (7R,8S,9R,7′R,8′R)-7,7′-diacetoxycubebin showed moderate protease inhibition at concentrations below 60 µM and other compounds showed insignificant inhibitory activities at concentrations above 100 µM. Additionally, the compounds (7S,8S,7’S,8’R)-7’-acetoxy-7-hydroxyhinokinin, (7S,8S,7’S,8’R)-7,7’-diacetoxyhinokinin, and (7R,8S,9R,7′R,8′R)-7,7′-diacetoxycubebin were also tested for cytotoxicity against the MCF-7 and MDA-MB-231 cancer cell lines and found to be inactive at concentrations below 90 µM


Share this article

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 4195

Medicinal Chemistry received 4195 citations as per Google Scholar report

Medicinal Chemistry peer review process verified at publons

Indexed In

arrow_upward arrow_upward